Alliancebernstein L.P. Recursion Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 361,374 shares of RXRX stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

361,374

Previous 252,514 43.11%

Holding current value

$1.97 Million

Previous $1.34 Million 36.93%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.97 - $5.84 $432,174 - $635,742	108,860 Added 43.11%	361,374 $1.83 Million
Q1 2025 May 15, 2025	BUY	$5.29 - $10.87 $49,197 - $101,091	9,300 Added 3.82%	252,514 $1.34 Million
Q4 2024 Feb 12, 2025	BUY	$5.7 - $8.27 $147,744 - $214,358	25,920 Added 11.93%	243,214 $1.64 Million
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $538,387 - $736,162	73,250 Added 50.85%	217,294 $1.63 Million
Q1 2024 May 14, 2024	SELL	$9.13 - $15.52 $610,541 - $1.04 Million	-66,872 Reduced 31.71%	144,044 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $243,271 - $515,697	47,794 Added 29.3%	210,916 $2.08 Million
Q3 2023 Nov 14, 2023	SELL	$6.59 - $15.86 $959,108 - $2.31 Million	-145,540 Reduced 47.15%	163,122 $1.25 Million
Q1 2023 May 15, 2023	SELL	$6.42 - $9.64 $526,074 - $789,930	-81,943 Reduced 20.98%	308,662 $2.06 Million
Q4 2022 Feb 14, 2023	SELL	$7.16 - $12.7 $20.4 Million - $36.2 Million	-2,846,739 Reduced 87.93%	390,605 $3.01 Million
Q3 2022 Nov 15, 2022	SELL	$7.83 - $13.6 $2.85 Million - $4.95 Million	-363,616 Reduced 10.1%	3,237,344 $34.4 Million
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $1.11 Million - $2.04 Million	220,242 Added 6.51%	3,600,960 $29.3 Million
Q1 2022 May 13, 2022	BUY	$6.16 - $18.03 $3.11 Million - $9.1 Million	504,899 Added 17.56%	3,380,718 $24.2 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $20 Million - $27 Million	1,236,478 Added 75.43%	2,875,819 $49.3 Million
Q3 2021 Nov 10, 2021	BUY	$19.03 - $41.33 $6.46 Million - $14 Million	339,419 Added 26.11%	1,639,341 $37.7 Million
Q2 2021 Jul 30, 2021	BUY	$18.0 - $37.42 $23.4 Million - $48.6 Million	1,299,922 New	1,299,922 $47.4 Million

Others Institutions Holding RXRX

# of Institutions

365

Shares Held

289M

Call Options Held

7.75M

Put Options Held

6.1M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $982M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Recursion Pharmaceuticals, Inc. Transaction History